152 related articles for article (PubMed ID: 17687003)
1. MEKK3 is required for endothelium function but is not essential for tumor growth and angiogenesis.
Deng Y; Yang J; McCarty M; Su B
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1404-11. PubMed ID: 17687003
[TBL] [Abstract][Full Text] [Related]
2. Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas.
Yu L; Su B; Hollomon M; Deng Y; Facchinetti V; Kleinerman ES
Cancer Res; 2010 Feb; 70(4):1334-43. PubMed ID: 20124484
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.
Zacharek A; Chen J; Cui X; Li A; Li Y; Roberts C; Feng Y; Gao Q; Chopp M
J Cereb Blood Flow Metab; 2007 Oct; 27(10):1684-91. PubMed ID: 17356562
[TBL] [Abstract][Full Text] [Related]
4. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
Indraccolo S
Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
[TBL] [Abstract][Full Text] [Related]
5. Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants.
Stratmann A; Acker T; Burger AM; Amann K; Risau W; Plate KH
Int J Cancer; 2001 Feb; 91(3):273-82. PubMed ID: 11169947
[TBL] [Abstract][Full Text] [Related]
6. T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model.
Bhattacharya D; Chaudhuri S; Singh MK; Chaudhuri S
Exp Mol Pathol; 2015 Jun; 98(3):455-66. PubMed ID: 25797371
[TBL] [Abstract][Full Text] [Related]
7. Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway.
DeBusk LM; Hallahan DE; Lin PC
Exp Cell Res; 2004 Aug; 298(1):167-77. PubMed ID: 15242771
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide produced by angiopoietin-1 mediates angiogenesis.
Kim YM; Kim KE; Koh GY; Ho YS; Lee KJ
Cancer Res; 2006 Jun; 66(12):6167-74. PubMed ID: 16778190
[TBL] [Abstract][Full Text] [Related]
9. Tie-1: A potential target for anti-angiogenesis therapy.
Yang P; Chen N; Jia JH; Gao XJ; Li SH; Cai J; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):615-622. PubMed ID: 26489611
[TBL] [Abstract][Full Text] [Related]
10. Tie2 in tumor endothelial signaling and survival: implications for antiangiogenic therapy.
Tsai JH; Lee WM
Mol Cancer Res; 2009 Mar; 7(3):300-10. PubMed ID: 19276184
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
12. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
Reynolds AR; Reynolds LE; Nagel TE; Lively JC; Robinson SD; Hicklin DJ; Bodary SC; Hodivala-Dilke KM
Cancer Res; 2004 Dec; 64(23):8643-50. PubMed ID: 15574772
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
Lin YC; Liu CY; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
[TBL] [Abstract][Full Text] [Related]
14. Acute depletion of endothelial β3-integrin transiently inhibits tumor growth and angiogenesis in mice.
Steri V; Ellison TS; Gontarczyk AM; Weilbaecher K; Schneider JG; Edwards D; Fruttiger M; Hodivala-Dilke KM; Robinson SD
Circ Res; 2014 Jan; 114(1):79-91. PubMed ID: 24103390
[TBL] [Abstract][Full Text] [Related]
15. Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor alpha-induced angiogenesis in rheumatoid arthritis.
DeBusk LM; Chen Y; Nishishita T; Chen J; Thomas JW; Lin PC
Arthritis Rheum; 2003 Sep; 48(9):2461-71. PubMed ID: 13130465
[TBL] [Abstract][Full Text] [Related]
16. MEKK3 is essential for lymphopenia-induced T cell proliferation and survival.
Wang X; Chang X; Facchinetti V; Zhuang Y; Su B
J Immunol; 2009 Mar; 182(6):3597-608. PubMed ID: 19265138
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
18. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade.
Huang J; Bae JO; Tsai JP; Kadenhe-Chiweshe A; Papa J; Lee A; Zeng S; Kornfeld ZN; Ullner P; Zaghloul N; Ioffe E; Nandor S; Burova E; Holash J; Thurston G; Rudge J; Yancopoulos GD; Yamashiro DJ; Kandel JJ
Int J Oncol; 2009 Jan; 34(1):79-87. PubMed ID: 19082480
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis.
Fukuhara S; Sako K; Noda K; Zhang J; Minami M; Mochizuki N
Histol Histopathol; 2010 Mar; 25(3):387-96. PubMed ID: 20054809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
